Abstract:This prospective multicenter intra-individual randomized controlled clinical trial was designed to compare the efficacy of guided tissue regeneration (GTR) with bioresorbable barrier membranes versus access flap surgery, in intrabony defects. 2 similar defects were selected in each of 23 patients and randomly assigned to 1 of the 2 treatments. Surgery consisted of an identical procedure except for the omission of the barrier membrane in the flap control sites. At 1-year, probing pocket depth reductions were 4.3+/-2.3 mm in GTR treated sites and 3.0+/-1.5 mm in the flap control sites (p=0.02, paired t-test). Clinical attachment level (CAL) gains were 3.0+/-1.7 mm in the GTR sites and 1.6+/-1.8 mm in the control sites (p=0.009, paired t-test). A subset analysis, performed according to the initial depth of the intrabony component of the defects (INFRA), indicated that in shallow defects (INFRA < or =3 mm) treated with the access flap alone, CAL gains were 1+/-1.5 mm, while in deep ones (INFRA > or =4 mm) they were consistently greater (1.9+/-1.9 mm). The % CAL gains, calculated as the % of the baseline intrabony component depth, however, were almost identical in the 2 subpopulations (45.8+/-64.7% in shallow and 43.8+/-37.6% in deep defects). Similarly, in the GTR sites, linear CAL gains were greater in deep (3.7+/-1.7 mm) than in shallow defects (2.2+/-1.3 mm), but no differences were observed in terms of % CAL gains (76.7+/-27.7% and 75.8+/-45%, respectively). The frequency distribution of CAL changes expressed as %s of the baseline INFRA indicates that most of the sites treated with GTR (73% in shallow and 92% in deep defects) gained 50% or more CAL. Furthermore, many defects (64% of shallow and 33% of deep defects) reached 100% of CAL gain. The present study demonstrated that: (i) GTR with bioresorbable barrier membranes resulted in a significant added benefit in comparison with access flap alone; (ii) the linear amounts of CAL gains were greater in deep than in shallow defects; (iii) CAL gains expressed as %s of the baseline depths of the intrabony component, were similar in shallow and deep defects; (iii) the regenerative procedure tested in the present study resulted in CAL gains equal to the depth of the intrabony component of the defect in some, but not in most of the instances.

Periodontal regeneration of human infrabony defects. II. Re-entry procedures and bone measures.

Periodontal regeneration of human infrabony defects. I. Clinical measures.

Periodontal Regeneration of Human Intrabony Defects. IV. Determinants of Healing Response

Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience

Periodontal Regeneration of Human Infrabony Defects. III. Diagnostic Strategies to Detect Bone Gain.

Guided tissue regeneration in the treatment of human infrabony defects. Clinical, radiographical and microbiological results: a pilot study

Periodontal Regeneration of Human Infrabony Defects (V) - Effect of Oral Hygiene on Long-Term Stability

Periodontal Infrabony Defects: Systematic Review of Healing by Defect Morphology Following Regenerative Surgery

Guided Tissue Regeneration of Deep Intrabony Defects in Strategically Important Prosthetic Abutments

Regeneration of infrabony periodontal defects in humans after implantation of allogenic demineralized dentin

Regenerative Periodontal Therapy in Intrabony Defects: State of the Art.

Periodontal Regeneration of Human Intrabony Defects with Bioresorbable Membranes. A Controlled Clinical Trial.

Microsurgical approach to periodontal regeneration. Initial evaluation in a case cohort.

Periodontal Regeneration Compared with Access Flap Surgery in Human Intrabony Defects 20-year Follow-up of a Randomized Clinical Trial: Tooth Retention, Periodontitis Recurrence and Costs.

Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial

Clinical effectiveness of regenerative periodontal surgery and orthodontic tooth movement with clear aligners in stage IV periodontitis: a case series

Optimizing esthetic zone periodontal regeneration in a 1-2-wall infrabony defect using recombinant human platelet-derived growth factor BB and β-tricalcium phosphate: A case report

Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes.

Treatment of peri-implantitis defects with autogenous bone grafts: six-month to 3-year results of a prospective study in 17 patients

Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery.

Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial.